Chest
Volume 127, Issue 6, June 2005, Pages 1875-1877
EditorialsBleeding Risk and Bronchoscopy: In Search of the Evidence in Evidence-Based Medicine
Section snippets
Acknowledgment
I would like to thank Dr. John T. Schaaf for his review of this article.
References (13)
- et al.
Effect of clopidogrel with and without aspirin on bleeding following transbronchial lung biopsy
Chest
(2005) Anticoagulants and cataract surgery
J Cataract Refract Surg
(1988)- et al.
Bronchoscopically induced bleeding: a summary of nine years' Cleveland Clinic experience and review of the literature
Chest
(1991) - et al.
Safety of bronchoscopy, biopsy, and BAL in research patients with COPD
Chest
(2002) Evidence-based medicine in the ICU
Chest
(2004)Transbronchial biopsy and needle aspiration
Chest
(1989)
There are more references available in the full text version of this article.
Cited by (18)
Fibreoptic bronchoscopy and anti-platelet agents: A risk-benefit analysis
2007, Revue des Maladies RespiratoiresAssociation between blood pressure and the risk of biopsy-induced endobronchial hemorrhage during bronchoscopy
2022, BMC Pulmonary MedicineClinical features and interventional bronchoscopic treatment of primary airway tumor in 8 children
2021, Zhonghua er ke za zhi / Chinese Journal of PediatricsThe hemorrhage risk of patients undergoing bronchoscopic examinations or treatments
2021, American Journal of Translational ResearchWhat is the value of electromagnetic navigation in lung cancer and to what extent does it require improvement?
2020, Expert Review of Respiratory Medicine
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).
Copyright © 2005 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.